MedTrace Logo

Using Self-evaluation to Increase Visit Intervals in Juvenile Idiopathic Arthritis

NCT05603286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2023-05-09

No results posted yet for this study

Summary

In the THUIS study, JIA patients in clinical remission will skip one 3-monthly hospital control visit and instead monitor their disease activity at home. Outcomes at 6 months will be compared to those from a historical cohort.

Conditions

  • JIA
  • Self-Evaluation

Interventions

PROCEDURE

Home-monitoring

Questionnaires for home-monitoring will be send to the participants 11 weeks after the baseline visit via e-mail using Castor EDC and can be completed using a computer, tablet or smartphone. Home-monitoring can be done together with a parent or guardian, if needed.

Sponsors & Collaborators

  • Joeri van Straalen

    lead OTHER

Principal Investigators

  • Joost Swart, MD, PhD · Department of Pediatric Immunology and Rheumatology, UMC Utrecht

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-28
Primary Completion
2023-04-01
Completion
2023-04-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05603286 on ClinicalTrials.gov